IBSA Institut Biochimique SA, the multinational pharmaceutical company based in Lugano, acquired 100% of the share capital of its UK distributor, Pharmasure Ltd. The purchase agreement was concluded in early May, and the UK Company’s name will change to IBSA Pharma Ltd.
“IBSA and Pharmasure have been collaborating successfully for more than 20 years. The acquisition is part of the Group’s strategy aimed at strengthening its commercial layout through the opening of its own subsidiaries. The UK is of strategic importance to the IBSA Group and acquiring Pharmasure will enable IBSA to further accelerate the growth of its fertility business as well as bringing its other therapy areas and new products into the IBSA Pharma portfolio”. Arturo Licenziati, President and CEO, IBSA Group.
Pharmasure Ltd is a major player in the UK reproductive medicine market, enjoying great success through its marketing and distribution of the IBSA products.
“I have enjoyed working closely with IBSA for more than 20 years and am delighted with this acquisition. Thanks to this move, Pharmasure will grow faster with many more opportunities for the business and for our employees”, Terry Sullivan, Pharmasure Founder and Managing Director.
Mr Sullivan, continues in his position post-acquisition as Managing Director.
Starting from now, he will be joined by Steven Knapp to whom full responsibility for managing the company will be transferred in the coming months.
